greeksoup/ stock research

Ecovyst Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 5 May 2026: press release. Guidance figures: 2 raised, 3 narrowed, 1 new, 5 kept. The quarter’s numbers.

Key takeaways

  • Sales rose 50 percent: Sales were $215.0 million, up $71.9 million or 50% from $143.1 million, reflecting higher selling prices and higher sales volume. Source
  • Adjusted EBITDA up 87 percent: Adjusted EBITDA was $39.8 million, up $18.5 million or 87%. Adjusted EBITDA margin was 18.5%, compared with 14.9% a year earlier. Source
  • Regeneration services grew double digits: Regeneration services sales grew at a double-digit pace, driven by high refinery utilization, favorable alkylate economics, lower customer downtime and favorable contractual pricing. Source
  • Virgin acid volumes up over 30 percent: Virgin sulfuric acid volumes rose more than thirty percent, reflecting continued solid demand and the contribution of the Waggaman assets. Source
  • Manufacturing costs rose on turnarounds: Adjusted EBITDA gains were partly offset by higher manufacturing costs from higher turnaround costs, general inflation and higher transportation costs. Source
  • Liquidity of $236.9 million: Cash was $162.6 million and ABL availability was $74.3 million; gross debt was $397.1 million, with no revolver borrowings outstanding. Source
  • Buybacks of $35.7 million in quarter: Repurchased 3,226,461 shares at an average $11.07, for $35.7 million; $146.5 million remains under the $450 million program, which no longer has an expiry date. Source

“Ecovyst delivered an excellent start to 2026, reinforcing our positive outlook for the year ahead.”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Sales Sourcefull year 2026$890 million to $970 millionRaised from $860 million to $940 million
Adjusted EBITDA Sourcefull year 2026approximately $180 million to $195 millionNarrowed, low end up from $175 million to $195 million
Adjusted Free Cash Flow Sourcefull year 2026$40 million to $55 millionNarrowed, low end up from $35 million to $55 million
Adjusted Diluted Income per share Sourcefull year 2026$0.50 to $0.65Narrowed, low end up from $0.45 to $0.65
Adjusted Net Income Sourcefull year 2026$55 million to $75 millionKept
Pass-through of sulfur costs in sales Sourcefull year 2026approximately $155 millionRaised from approximately $125 million
Capital expenditures Sourcefull year 2026$80 million to $90 millionKept
Interest expense Sourcefull year 2026$18 million to $22 millionKept
Depreciation and amortization Sourcefull year 2026$78 million to $82 millionKept
Effective tax rate Sourcefull year 2026mid 20% rangeKept
Growth capital projects Source2026approximately $20 millionNew

What changed from last quarter

  • Guidance raised: Full-year 2026 sales range raised from $860 million to $940 million to $890 million to $970 million. Source
  • Guidance raised: Full-year Adjusted EBITDA low end raised from $175 million to approximately $180 million; top end unchanged at $195 million. Source
  • Guidance raised: Full-year Adjusted Free Cash Flow low end raised from $35 million to $40 million; top end unchanged at $55 million. Source
  • Guidance raised: Projected pass-through of sulfur costs in 2026 sales raised from approximately $125 million to approximately $155 million. Source
  • New: Approximately $20 million is being invested in two projects in 2026, a specific figure not given in the prior release. Source

Results and growth drivers

  • Sales rose 50 percent: Sales were $215.0 million, up $71.9 million or 50% from $143.1 million, reflecting higher selling prices and higher sales volume. Source
  • Adjusted EBITDA up 87 percent: Adjusted EBITDA was $39.8 million, up $18.5 million or 87%. Adjusted EBITDA margin was 18.5%, compared with 14.9% a year earlier. Source
  • Net income positive after prior loss: Net income from continuing operations was $5.7 million, against a loss of $8.1 million; diluted income per share was $0.05, against a loss of $0.07. Source

Products and customers

  • Regeneration services grew double digits: Regeneration services sales grew at a double-digit pace, driven by high refinery utilization, favorable alkylate economics, lower customer downtime and favorable contractual pricing. Source
  • Virgin acid volumes up over 30 percent: Virgin sulfuric acid volumes rose more than thirty percent, reflecting continued solid demand and the contribution of the Waggaman assets. Source
  • Waggaman and downtime added volume: Sales volume increase came from the Waggaman location, higher virgin acid demand and higher regeneration services with less customer downtime than a year earlier. Source

“and as such we are revising our full-year Adjusted EBITDA guidance”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Costs, margins and pricing

  • Sulfur pass-through raised selling prices: Pass-through of higher sulfur costs, about $33 million, lifted average selling prices, along with higher virgin acid pricing and favorable regenerated acid contract pricing. Source
  • Manufacturing costs rose on turnarounds: Adjusted EBITDA gains were partly offset by higher manufacturing costs from higher turnaround costs, general inflation and higher transportation costs. Source
  • Gross profit and operating income rose: Gross profit was $36.4 million against $19.1 million; SG&A was $19.1 million against $16.5 million; operating income was $12.5 million against a $1.0 million loss. Source
  • Lower interest and tax rate higher: Interest expense, net was $3.2 million against $8.3 million; debt modification costs were nil against $1.0 million; effective tax rate was 38.4% against 21.6%. Source

Demand and 2026 view

  • Positive 2026 demand projected: The company projects positive demand in 2026 for sales of both regenerated and virgin sulfuric acid. Source
  • Mining drives higher virgin acid sales: Higher virgin acid sales are expected in 2026, reflecting increased sales into mining applications. Source
  • Refinery economics support regeneration sales: High refinery utilization, favorable alkylate economics and lower customer downtime, against 2025, are expected to lift regenerated acid sales in 2026. Source

“provides meaningful flexibility to accelerate growth through both organic investments and accretive inorganic opportunities”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Portfolio and discontinued operations

  • Advanced Materials sale completed: The Advanced Materials & Catalysts business, including the Zeolyst investments, was sold on December 31, 2025, and is reported in discontinued operations. Source
  • Discontinued operations loss in quarter: Net loss from discontinued operations was $1.4 million, against income of $4.5 million a year earlier; total net income was $4.3 million. Source
  • Continuing figures exclude divested business: Results of the divested business are reported in discontinued operations for all periods presented, so the continuing figures exclude it. Source

Capital, cash and shareholder returns

  • Operating cash flow rose: Operating cash flow from continuing operations was $19.6 million, against $6.7 million; Adjusted Free Cash Flow was $4.2 million, against negative $13.0 million. Source
  • Liquidity of $236.9 million: Cash was $162.6 million and ABL availability was $74.3 million; gross debt was $397.1 million, with no revolver borrowings outstanding. Source
  • Leverage ratios stated at quarter end: Net debt leverage ratio was 1.2x; net debt to net income ratio was 11.7x, compared with 31.7x at December 31, 2025 in the prior release. Source
  • Buybacks of $35.7 million in quarter: Repurchased 3,226,461 shares at an average $11.07, for $35.7 million; $146.5 million remains under the $450 million program, which no longer has an expiry date. Source
  • Capital spending lower than prior year: Purchases of property, plant and equipment from continuing operations were $14.1 million, against $17.1 million a year earlier. Source

Strategy and investment

  • Balance sheet supports growth options: Management says the divestiture gives flexibility to accelerate growth through both organic investment and accretive inorganic deals. Source
  • Positioning as US sulfur supplier: Management describes Ecovyst as a leading U.S.-based supplier of critical sulfur products and services, and expects to build on 2026 growth. Source
  • Two virgin acid projects funded: About $20 million is being spent on two projects in 2026 to serve the growing virgin sulfuric acid customer base. Source

Coming up, as management said on 5 May 2026

  • Continued capital allocation focus: Management says it will keep prioritizing capital allocation options for long-term stockholder value, without a dated event. Source

In management's words

“We also returned approximately $36 million to stockholders through share repurchases in the first quarter”

Kurt J. Bitting, Ecovyst’s Chief Executive Officer

Figures management reported

FigureReported
Virgin sulfuric acid volume growth Sourcemore than 30%
Regeneration services sales growth Sourcedouble-digit pace

Risks management discussed

  • Demand: Management is cautious about possible softer demand in some industrial applications for virgin sulfuric acid. Source
  • External: Management cites an evolving geopolitical and global macroeconomic landscape as a factor in its view for 2026. Source
  • Operational: Manufacturing costs rose on higher turnaround costs, general inflation and higher transportation costs. Source
  • External: The sales range assumes higher average sulfur prices in 2026 than in 2025, together with higher projected pass-through of sulfur costs. Source

Earlier plans management reported on

  • Not stated: In the prior release management said it planned to keep pursuing inorganic growth and an active share repurchase program.
  • Not stated: Management continues to project positive 2026 demand for both regenerated and virgin sulfuric acid sales. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.